Vaccinations in Patients with Rheumatic Disease: Consider Disease and Therapy.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 33589098.
- Also identified by DOI 10.1016/j.mcna.2020.09.008.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Patients with rheumatic diseases are susceptible to infections due to their underlying disease states as well as from immunosuppressive medications, highlighting the importance of vaccination, these same factors also pose challenges to vaccine efficacy, safety, and uptake. This article reviews the impact of immunosuppressive therapies and rheumatic disease on vaccine efficacy in this vulnerable patient population as well as discusses best practices.
Medical subject headings
- Antirheumatic Agents
- Biological Products
- Immunogenicity, Vaccine
- Immunosuppressive Agents
- Rheumatic Diseases
- Vaccination
- Vaccines